Relationship between N-Terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Wirth, Janine ^a   Buijsse, Brian ^a   Di Giuseppe, Romina ^a   Fritsche, Andreas ^b   Hense, Hans W ^c   Westphal, Sabine ^d   Isermann, Berend ^d   Boeing, Heiner ^a   Weikert, Cornelia ^a,e  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMAN (CITIZEN); HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; GERMANY; METABOLISM; RISK FACTOR;

ADULT; AGED; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; RISK FACTORS;

EID: 84913553800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113710     Document Type: Article

References (35)

1. Kannel WB (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5:167-173.
2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803-869.
3. Daniels LB, Maisel AS (2007) Natriuretic peptides. JACC 50:2357-2368.
4. Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257-260.
5. Choi HS, Kim KH, Yoon HJ, Hong YJ, Kim JH, et al. (2012) Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism. J Cardiol 60:508-513.
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388-2442.
7. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, et al. (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120:2177-2187.
8. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, et al. (2010) Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. JACC 56:1712-1719.
9. Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, et al. (2010) Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension 55:785-791.
10. McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, et al. (2010) The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. JACC 55:2140-2147.
11. Kalogeropoulos AP, Georgiopoulou VV, deFilippi CR, Gottdiener JS, Butler J (2012) Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study. JACC Cardiovascular imaging 5:131-140.
12. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, et al. (2002) Obesity and the risk of heart failure. N Engl J Med 347:305-313.
13. Baessler A, Strack C, Rousseva E, Wagner F, Bruxmeier J, et al. (2012) Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity. Eur J Heart Fail 14:1240-1248.
14. Habbu A, Lakkis NM, Dokainish H (2006) The obesity paradox: fact or fiction? Am J Cardiol 98:944-948.
15. Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, et al. (2010) Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality. Clin Chem 56:633-641.
16. Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, et al. (2011) Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart 97:551-556.
17. Rivera M, Cortes R, Salvador A, Bertomeu V, de Burgos FG, et al. (2005) Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 7:1168-1170.
18. Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, et al. (2011) Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol 108:979-984.
19. Boeing H, Wahrendorf J, Becker N (1999) EPIC-Germany-A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:195-204.
20. Bergmann MM, Bussas U, Boeing H (1999) Follow-up procedures in EPIC-Germany - data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43:225-234.
21. di Giuseppe R, Buijsse B, Hirche F, Wirth J, Arregui M, et al. (2013) Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-HydroxyvitaminD3 and risk of Heart Failure: a prospective, case-cohort study. J Clin Endocrinol Metab 99:947-55.
22. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, et al. (2005) [Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]. Rev Esp Cardiol 58:1062-1092.
23. di Giuseppe R, Pechlivanis S, Fisher E, Arregui M, Weikert B, et al. (2013) Microsomal triglyceride transfer protein -164 T>C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study. BMC Med Genet 14:19.
24. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, et al. (2002) Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1147-1162.
25. Prentice R (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73:1-11.
26. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239-241.
27. Choi SG, Jeong MH, Ahn Y, Cho JG, Kang JC, et al. (2010) Relationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction. Korean Circ J 40:558-564.
28. Frankenstein L, Remppis A, Nelles M, Schaelling B, Schellberg D, et al. (2008) Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 29:2634-2640.
29. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, et al. (2007) Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167:400-407.
30. Semenov AG, Postnikov AB, Tamm NN, Seferian KR, Karpova NS, et al. (2009) Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 55:489-498.
31. Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, et al. (2011) Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 96:3242-3249.
32. Pivovarova O, Gogebakan O, Kloting N, Sparwasser A, Weickert MO, et al. (2012) Insulin upregulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 97:E731-739.
33. Carlsson AC, Riserus U, Engstrom G, Arnlov J, Melander O, et al. (2013) Novel and established anthropometric measures and the prediction of incident cardiovascular disease: a cohort study. Int J Obes 37:1579-85.
34. Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, et al. (2013) Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes 2013:269038.
35. Shimabukuro M, Higa N, Asahi T, Yamakawa K, Oshiro Y, et al. (2011) Impaired glucose tolerance, but not impaired fasting glucose, underlies left ventricular diastolic dysfunction. Diabetes care 34:686-690.